Cardio Diagnostics (CDIOW) Projected to Post Quarterly Earnings on Wednesday

Cardio Diagnostics (NASDAQ:CDIOW) is projected to post its results before the market opens on Wednesday, February 25th. Analysts expect Cardio Diagnostics to post earnings of ($1.80) per share and revenue of $0.25 million for the quarter.

Cardio Diagnostics Price Performance

Shares of Cardio Diagnostics stock opened at $0.03 on Monday. Cardio Diagnostics has a 52-week low of $0.01 and a 52-week high of $0.09. The business’s 50 day simple moving average is $0.02 and its 200 day simple moving average is $0.02.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.